Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Peking University · Peking University Cancer Hospital · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
946
total citations
- FWCI
- 63.41
- Percentile
- 100%
- References
- 39
Citations per year
Authors
35- YSYing Sun
Peking University, Peking University Cancer Hospital, Sun Yat-sen University, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
- WLWen-Fei Li
Sun Yat-sen University, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
- NCNian-Yong Chen
Sichuan University
- NZNing Zhang
First People's Hospital of Foshan
- GHGuoqing Hu
Huazhong University of Science and Technology, Tongji Hospital
Topics & keywords
Topics
Keywords
- Medicine
- Docetaxel
- Induction chemotherapy
- Chemoradiotherapy
- Nasopharyngeal carcinoma
- Internal medicine
- Clinical endpoint
- Fluorouracil
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.